These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26428874)

  • 1. Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents.
    Brogi S; Brindisi M; Joshi BP; Sanna Coccone S; Parapini S; Basilico N; Novellino E; Campiani G; Gemma S; Butini S
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5412-8. PubMed ID: 26428874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore.
    Gemma S; Campiani G; Butini S; Kukreja G; Joshi BP; Persico M; Catalanotti B; Novellino E; Fattorusso E; Nacci V; Savini L; Taramelli D; Basilico N; Morace G; Yardley V; Fattorusso C
    J Med Chem; 2007 Feb; 50(4):595-8. PubMed ID: 17263523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-QSAR Modeling and Synthesis of New Fusidic Acid Derivatives as Antiplasmodial Agents.
    Kaur G; Pavadai E; Wittlin S; Chibale K
    J Chem Inf Model; 2018 Aug; 58(8):1553-1560. PubMed ID: 30040885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
    Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
    Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling.
    Gemma S; Kukreja G; Campiani G; Butini S; Bernetti M; Joshi BP; Savini L; Basilico N; Taramelli D; Yardley V; Bertamino A; Novellino E; Persico M; Catalanotti B; Fattorusso C
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3535-9. PubMed ID: 17493808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: further structure-activity relationships, in vivo studies, and preliminary toxicity profiling.
    Gemma S; Camodeca C; Sanna Coccone S; Joshi BP; Bernetti M; Moretti V; Brogi S; Bonache de Marcos MC; Savini L; Taramelli D; Basilico N; Parapini S; Rottmann M; Brun R; Lamponi S; Caccia S; Guiso G; Summers RL; Martin RE; Saponara S; Gorelli B; Novellino E; Campiani G; Butini S
    J Med Chem; 2012 Aug; 55(15):6948-67. PubMed ID: 22783984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions.
    Prasanth Kumar S; Jasrai YT; Pandya HA; Rawal RM
    J Biomol Struct Dyn; 2015; 33(1):56-69. PubMed ID: 24266725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofazimine analogs with antileishmanial and antiplasmodial activity.
    Barteselli A; Casagrande M; Basilico N; Parapini S; Rusconi CM; Tonelli M; Boido V; Taramelli D; Sparatore F; Sparatore A
    Bioorg Med Chem; 2015 Jan; 23(1):55-65. PubMed ID: 25497962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining 4-aminoquinoline- and clotrimazole-based pharmacophores toward innovative and potent hybrid antimalarials.
    Gemma S; Campiani G; Butini S; Joshi BP; Kukreja G; Coccone SS; Bernetti M; Persico M; Nacci V; Fiorini I; Novellino E; Taramelli D; Basilico N; Parapini S; Yardley V; Croft S; Keller-Maerki S; Rottmann M; Brun R; Coletta M; Marini S; Guiso G; Caccia S; Fattorusso C
    J Med Chem; 2009 Jan; 52(2):502-13. PubMed ID: 19113955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
    Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
    Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR studies on Plasmodium falciparam proteins: a mini-review.
    Divakar S; Hariharan S
    Comb Chem High Throughput Screen; 2015; 18(2):188-98. PubMed ID: 25543683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Antiplasmodial Activity of Novel Chloroquine Analogues with Bulky Basic Side Chains.
    Tasso B; Novelli F; Tonelli M; Barteselli A; Basilico N; Parapini S; Taramelli D; Sparatore A; Sparatore F
    ChemMedChem; 2015 Sep; 10(9):1570-83. PubMed ID: 26213237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
    Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
    Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
    Neves BJ; Bueno RV; Braga RC; Andrade CH
    Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline.
    Casagrande M; Barteselli A; Basilico N; Parapini S; Taramelli D; Sparatore A
    Bioorg Med Chem; 2012 Oct; 20(19):5965-79. PubMed ID: 22917857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.